Apnimed (NASDAQ:APMD) soars 56% as FDA decision could push sleep-apnea valuation close to $1 billion

Apnimed Inc. finished its first session on Nasdaq at $25, representing a 56.25% increase from its IPO price of $16. Market data indicated a market capitalization close to $950 million. The regular session had ended, but after-hours trading was still ongoing. The stock was last quoted at $23, reflecting an 8% drop from the closing price.

1 August 2026

#1

Walmart earnings

Walmart has the potential to influence outlooks on U.S. consumer strength, grocery inflation, discretionary spending, and retail profit margins.

#2

8:30 ET macro cluster

Jobless claims and the Philadelphia Fed survey often influence Treasury yields, the US dollar, and equity index futures ahead of the market open.

#3

Deere earnings

Outlooks for large agriculture demand and construction equipment are key indicators for industrial cyclicals and the broader farm economy.

View full calendar